Our findings suggest that a reduction in BDNF/Trk-B signaling contributes to changes in lipid metabolism that lead to hepatic steatosis and obesity, which are symptoms of the metabolic syndrome. This evidence concerns the gene NTRK2 and obesity due to melanocortin 4 receptor deficiency.